Robert T. Jacobs

3.1k total citations
43 papers, 1.9k citations indexed

About

Robert T. Jacobs is a scholar working on Molecular Biology, Organic Chemistry and Epidemiology. According to data from OpenAlex, Robert T. Jacobs has authored 43 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 17 papers in Organic Chemistry and 16 papers in Epidemiology. Recurrent topics in Robert T. Jacobs's work include Trypanosoma species research and implications (15 papers), Research on Leishmaniasis Studies (9 papers) and Synthesis and Biological Evaluation (9 papers). Robert T. Jacobs is often cited by papers focused on Trypanosoma species research and implications (15 papers), Research on Leishmaniasis Studies (9 papers) and Synthesis and Biological Evaluation (9 papers). Robert T. Jacobs collaborates with scholars based in United States, Switzerland and United Kingdom. Robert T. Jacobs's co-authors include Bakela Nare, Barry Greenberg, Jacob J. Plattner, Robert Don, Jenny McKay, Paul J. Ciaccio, R.A. Gadient, Anna Zacco, François Pognan and Claude Dagenais and has published in prestigious journals such as The Lancet, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Robert T. Jacobs

43 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert T. Jacobs United States	27	755	625	515	413	208	43	1.9k
Richard J. Sciotti United States	25	537 0.7×	623 1.0×	347 0.7×	543 1.3×	120 0.6×	48	1.6k
Michael P. Pollastri United States	26	666 0.9×	653 1.0×	651 1.3×	587 1.4×	80 0.4×	69	1.8k
Adriane R. Todeschini Brazil	30	1.7k 2.3×	648 1.0×	670 1.3×	329 0.8×	201 1.0×	74	2.8k
Julie A. Frearson United Kingdom	25	998 1.3×	707 1.1×	714 1.4×	723 1.8×	146 0.7×	43	2.2k
Marvin J. Meyers United States	27	1.2k 1.6×	669 1.1×	370 0.7×	239 0.6×	338 1.6×	62	3.0k
Megan H. Wright United Kingdom	23	1.2k 1.6×	411 0.7×	312 0.6×	350 0.8×	161 0.8×	42	2.1k
Simon A. Osborne United Kingdom	20	628 0.8×	360 0.6×	416 0.8×	425 1.0×	72 0.3×	42	1.5k
Kohei Yokoyama United States	30	1.5k 2.0×	754 1.2×	389 0.8×	510 1.2×	269 1.3×	68	2.6k
Yew Mun Lee Singapore	20	825 1.1×	237 0.4×	235 0.5×	362 0.9×	197 0.9×	33	1.7k
Tsutomu Akama Japan	20	935 1.2×	1.0k 1.6×	331 0.6×	109 0.3×	215 1.0×	33	2.2k

Countries citing papers authored by Robert T. Jacobs

Since Specialization

Citations

This map shows the geographic impact of Robert T. Jacobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert T. Jacobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert T. Jacobs more than expected).

Fields of papers citing papers by Robert T. Jacobs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert T. Jacobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert T. Jacobs. The network helps show where Robert T. Jacobs may publish in the future.

Co-authorship network of co-authors of Robert T. Jacobs

This figure shows the co-authorship network connecting the top 25 collaborators of Robert T. Jacobs. A scholar is included among the top collaborators of Robert T. Jacobs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert T. Jacobs. Robert T. Jacobs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Padilla, Ángel M., Wei Wang, Tsutomu Akama, et al.. (2022). Discovery of an orally active benzoxaborole prodrug effective in the treatment of Chagas disease in non-human primates. Nature Microbiology. 7(10). 1536–1546. 39 indexed citations

Butler, Michelle M., Samanthi L. Waidyarachchi, Son T. Nguyen, et al.. (2022). Optimized Pyridazinone Nutrient Channel Inhibitors Are Potent and Specific Antimalarial Leads. Molecular Pharmacology. 102(3). 172–182. 5 indexed citations

Ehrens, Alexandra, Christopher S. Lunde, Robert T. Jacobs, et al.. (2020). In vivo efficacy of the boron-pleuromutilin AN11251 against Wolbachia of the rodent filarial nematode Litomosoides sigmodontis. PLoS neglected tropical diseases. 14(1). e0007957–e0007957. 12 indexed citations

Lunde, Christopher S., Erin E. Stebbins, Rajiv S. Jumani, et al.. (2019). Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis. Nature Communications. 10(1). 2816–2816. 44 indexed citations

Steketee, Pieter C., Isabel M. Vincent, Fiona Achcar, et al.. (2018). Benzoxaborole treatment perturbs S-adenosyl-L-methionine metabolism in Trypanosoma brucei. PLoS neglected tropical diseases. 12(5). e0006450–e0006450. 44 indexed citations

Bocxlaer, Katrien Van, Eric Gaukel, Vanessa Yardley, et al.. (2018). Topical Treatment for Cutaneous Leishmaniasis: Dermato-Pharmacokinetic Lead Optimization of Benzoxaboroles. Antimicrobial Agents and Chemotherapy. 62(5). 29 indexed citations

Zhang, Yong-Kang, Jacob J. Plattner, Eric E. Easom, et al.. (2017). Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate. Journal of Medicinal Chemistry. 60(13). 5889–5908. 53 indexed citations

Akama, Tsutomu, Yong-Kang Zhang, Yvonne R. Freund, et al.. (2017). Identification of a 4-fluorobenzyl l-valinate amide benzoxaborole (AN11736) as a potential development candidate for the treatment of Animal African Trypanosomiasis (AAT). Bioorganic & Medicinal Chemistry Letters. 28(1). 6–10. 33 indexed citations

Zhang, Jiong, et al.. (2014). Novel pyrrolobenzoxaboroles: Design, synthesis, and biological evaluation against Trypanosoma brucei. European Journal of Medicinal Chemistry. 81. 59–75. 20 indexed citations

10.

Akama, Tsutomu, Chen Dong, Yvonne R. Freund, et al.. (2013). Discovery and structure–activity relationships of 6-(benzoylamino)benzoxaboroles as orally active anti-inflammatory agents. Bioorganic & Medicinal Chemistry Letters. 23(21). 5870–5873. 18 indexed citations

11.

Bowling, Tana, Luke Mercer, Robert Don, Robert T. Jacobs, & Bakela Nare. (2012). Application of a resazurin-based high-throughput screening assay for the identification and progression of new treatments for human African trypanosomiasis. International Journal for Parasitology Drugs and Drug Resistance. 2. 262–270. 65 indexed citations

12.

Freeman, Jennifer C., Cyrus J. Bacchi, Tana Bowling, et al.. (2011). SAR of 2-amino and 2,4-diamino pyrimidines with in vivo efficacy against Trypanosoma brucei. Bioorganic & Medicinal Chemistry Letters. 21(10). 2816–2819. 7 indexed citations

13.

Ding, Dazhong, Yaxue Zhao, Qing Wang, et al.. (2011). Design, Synthesis, and Structure−Activity Relationship of Trypanosoma brucei Leucyl-tRNA Synthetase Inhibitors as Antitrypanosomal Agents. Journal of Medicinal Chemistry. 54(5). 1276–1287. 71 indexed citations

14.

Milano, Joseph, Jenny McKay, Claude Dagenais, et al.. (2004). Modulation of Notch Processing by γ-Secretase Inhibitors Causes Intestinal Goblet Cell Metaplasia and Induction of Genes Known to Specify Gut Secretory Lineage Differentiation. Toxicological Sciences. 82(1). 341–358. 432 indexed citations

15.

Scott, Clay W., Deidre Wilkins, Robert T. Jacobs, et al.. (2003). Novel Small Molecule Inhibitors of Caspase-3 Block Cellular and Biochemical Features of Apoptosis. Journal of Pharmacology and Experimental Therapeutics. 304(1). 433–440. 48 indexed citations

16.

Tian, Gaochao, David Aharony, Ashok B. Shenvi, et al.. (2003). The Mechanism of γ-Secretase. Journal of Biological Chemistry. 278(31). 28968–28975. 61 indexed citations

17.

Veale, Chris A., David Aharony, Debra L. Banville, et al.. (2000). The discovery of non-basic atrial natriuretic peptide clearance receptor antagonists. part 1. Bioorganic & Medicinal Chemistry Letters. 10(17). 1949–1952. 28 indexed citations

18.

Jacobs, Robert T., et al.. (1998). 4-Alkylpiperidines related to SR-48968: Potent antagonists of the neurokinin-2 (NK2) receptor. Bioorganic & Medicinal Chemistry Letters. 8(14). 1935–1940. 6 indexed citations

19.

Jacobs, Robert T., Peter R Bernstein, Edward P. Vacek, et al.. (1994). Synthesis, Structure-Activity Relationships, and Pharmacological Evaluation of a Series of Fluorinated 3-Benzyl-5-Indolecarboxamides: Identification of 4-[[5-[((2R)-2-Methyl-4,4,4-trifluorobutyl)carbamoyl]-1-methylindol-3-yl]methyl]-3methoxy-N-[(2-methylphenyl)sulfonyl]benzamide, a Potent, Orally Active Antagonist of Leukotrienes D4 and E4. Journal of Medicinal Chemistry. 37(9). 1282–1297. 28 indexed citations

20.

Jacobs, Robert T., et al.. (1993). Substituted 3-(phenylmethyl)-1H-indole-5-carboxamides and 1-(phenylmethyl)indole-6-carboxamides as potent, selective, orally active antagonists of the peptidoleukotrienes. Journal of Medicinal Chemistry. 36(3). 394–409. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact